Table 1.
Demographics
| Study population N (%) |
DLB 0–1a N (%) |
DLB 2–4b N (%) |
Anti-dementia medicationc N (%) |
Antipsychotic medicationd N (%) |
|
|---|---|---|---|---|---|
| Sex N (%) | |||||
| Male | 146 (24) | 112 (77) | 34 (23) | 51 (38) | 31 (21) |
| Female | 464 (76) | 374 (81) | 90 (19) | 141 (32) | 101 (22) |
| Dementia diagnosis | |||||
| Yes N (%) | 440 (74) | 348 (79) | 92 (21) | 192 (45) | 102 (23) |
| Different dementia diagnosese | |||||
| Alzheimer’s disease | 115 (26) | 92 (80) | 23 (20) | 71 (64) | 30 (26) |
| Alzheimer’s mixed | 97 (22) | 83 (86) | 14 (14) | 66 (69) | 25 (26) |
| Vascular dementia | 85 (19) | 69 (81) | 16 (19) | 5 (6) | 20 (24) |
| DLB/PDDf | 22 (5) | 2 (9) | 20 (91) | 13 (62) | 5 (23) |
| Dementia NOSg | 121 (28) | 102 (84) | 19 (16) | 37 (32) | 22 (18) |
aDLB 0–1: none or one clinical feature of dementia with Lewy bodies (DLB)
bDLB 2–4: two or more DLB clinical features
cAnti-dementia medication (N06D)
dAntipsychotic medication (N05A)
eDementia diagnoses found in 440 (100%) residents
fDLB/PDD: DLB/Parkinson’s disease with dementia
gDementia NOS: dementia not otherwise specified